Dianthus Therapeutics, Inc. (DNTH) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Dianthus Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -9.59x | -8.55x | -1.23x | -0.83x | -18.57x | -4.60x |
| P/B Ratio | 3.16x | 2.06x | 0.32x | 0.32x | 1.41x | 2.39x |
| P/S Ratio | 764.98x | 116.48x | 18.97x | 3.69x | 164.92x | 0.00x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% |
| Operating Margin | -8739.3% | -1633.7% | -1704.7% | -462.9% | -886.6% | 0.0% |
| Net Margin | -7973.3% | -1362.8% | -1541.2% | -443.8% | -888.1% | 0.0% |
| EBITDA Margin | -8739.3% | -1627.1% | -1692.1% | -460.6% | -886.6% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 13.32x | 15.22x | 18.42x | 9.97x | 16.63x | 13.26x |
| Quick Ratio | 13.32x | 15.22x | 18.42x | 9.97x | 16.63x | 13.26x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..